法规动态

FDA、EMA、TGA 及全球法规动态

#Rabeprazole ×

2026年8月30日•1 分钟阅读

FDA Approves ANDA076885 for Rabeprazole Sodium

FDA has approved ANDA076885 for Rabeprazole Sodium oral delayed‑release tablets (20 mg) sponsored by Pharmobedient, with multiple labeling submissions approved between 2013 and 2023.